شرکت‌سرم‌سازی‌شهیدقاضی‌تبریز

دقاضی | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 24,040 1.78
Close Price: 23,520

Financial Ratios

2026/07/07
Fiscal Year 2026/03/2012 Month
2025/05/07
Fiscal Year 2025/03/2012 Month
2024/05/08
Fiscal Year 2024/03/1912 Month

Net Profit to Sales

43.1340.2637.47

Gross Profit to Sales

53.1747.5549.08

Operating Margin

59.6552.252.72

Gross Profit to Sales

61.7855.2955.42

Net Profit to Gross Profit

69.8172.8167.6

Return on Assets (ROA)

32.7227.634.65

Return on Capital (%)

152.3785.42354.3

Return on Equity (ROE)

53.4243.8972.67

Working Capital Return

71.6170.01135.59

Fixed Asset Return

139.377.75154.06

Loan Benefit Assessment

1.631.592.1

Current Ratio

2.492.591.5

Quick Ratio

1.962.041.18

Liquidity Ratio

0.060.140.12

Net Working Capital

22,108,11612,066,2624,442,286

Current Assets Ratio

0.760.640.77

Inventory Turnover

157.54136.29154.85

Receivables Collection Period

216.79224.43169.39

Inventory to Working Capital

0.360.340.64

Working Capital Turnover

1.661.743.62

Fixed Asset Turnover

3.231.934.11

Total Asset Turnover

0.760.690.92

Debt Ratio

0.390.370.52

Debt to Equity

0.630.591.1

Long-Term Debt to Equity

0.130.20.02

Current Debt to Equity

0.50.391.08

Equity Ratio

61.2662.8747.69

Debt Coverage Ratio

2.892.8828.5